By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Theravance, Inc. 

951 Gateway Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-808-6000 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Theravance (THRX) Reports Second Quarter 2015 Financial Results 7/30/2015 1:14:43 PM
Theravance (THRX) To Report Second Quarter 2015 Financial Results On July 29, 2015 7/24/2015 12:36:36 PM
Theravance (THRX) Announces Health Canada Approval For VIBATIV (telavancin) for Treatment of HAP/VAP Caused By Gram-Positive Bacteria, Including MRSA 7/23/2015 8:43:34 AM
Theravance (THRX) To Present At The Bank of America (BAC) Merrill Lynch 2015 Healthcare Conference 5/8/2015 10:02:27 AM
Theravance (THRX) Reports First Quarter 2015 Financial Results 5/7/2015 1:33:21 PM
Theravance (THRX) Announces New Employment Inducement Awards 5/4/2015 4:11:01 PM
Theravance (THRX) To Report First Quarter 2015 Financial Results On May 6, 2015 4/30/2015 11:13:25 AM
Theravance (THRX) Announces New Employment Inducement Awards 4/6/2015 10:16:43 AM
GlaxoSmithKline (GSK) And Theravance (THRX) Announce Outcome Of US FDA Advisory Committee On BREO ELLIPTA In Asthma 3/20/2015 11:19:41 AM
Theravance (THRX) Announces Trading In Common Stock Halted 3/20/2015 11:11:03 AM
12345678910...
//-->